Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Another Week Down
View:
Post by Bunge on May 14, 2021 3:13pm

Another Week Down

So will we go up in increments of 5c, 10c, 20c, 30c, $1 when we eventually hit?

I'd be happy with a simple quick run to $1.21/share.

:)
Comment by Tapps21 on May 14, 2021 3:43pm
Really? A potential cure for the big C in many applications, potential virus vax and you want $1.21  Maybe move the decimal over one more spot (to the right) and we will talk.  Do I have it wrong?
Comment by charlierock on May 14, 2021 3:54pm
No Tapps you have it right. I think it's safe to say most who have their hard earned money invested here have very lofty expectations and rightfully so. We all know the story. The markets just waiting for the data that will confirm it.
Comment by Bunge on May 14, 2021 5:24pm
You're not wrong. The $1.21 was short term like 3 months from now. Gets us on the right track. $11.21 will be 2022. ;)  
Comment by Pandora on May 14, 2021 6:39pm
Well at least the $0.21 part seems to be fairly consistent over the last few years. Amazing how much optimism there can be to have a digit other than zero on the other side of the decimal point. When was the last time? Chart shows 'never'. Chart also shows a 'high' being achieved 7 years ago --  2014.
Comment by Tapps21 on May 14, 2021 7:32pm
Well "records", even small ones, were mean't to be broken. What are we all waiting for day after day here?  Some of us Bit-chin and moanin about irrelevant garbage. I only read the mature content. We all want the big dough  (Vegas trip) through the success of TLT. We all think this comany is going to the moon one day don't we?  Maybe so but not until after we see ...more  
Comment by ScienceFirst on May 14, 2021 4:58pm
Bungee once again talking about a share price!   He has to regain credibility to wifey's eyes! The guy never posted a single R&D post in 7 years!  But he's all there to post about his lazzy libertarian views. ___________________________ Bunge - (5/14/2021 3:13:19 PM) Another Week Down So will we go up in increments of 5c, 10c, 20c, 30c, $1 when we ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250